Source:http://linkedlifedata.com/resource/pubmed/id/14613626
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2003-11-17
|
pubmed:abstractText |
The clinical features of the primary Plasmodium falciparum infections in 25 children, and of the recrudescent infections that emerged after pyrimethamine-sulfadoxine (PS) treatment of the children had failed, were evaluated. In addition, the gametocyte sex ratios in these children and in age- and gender-matched controls who had PS-sensitive (PS-S) infections were also examined. Compared with the primary infections, the recrudescent infections were accompanied by significantly fewer symptoms and lower levels of parasitaemia but significantly higher gametocytaemia:parasitaemia ratios. Although the mean gametocyte sex ratio was female-biased pre-treatment, in both the PS-resistant (PS-R) and PS-S infections it became male-biased on days 7 and 14 post-treatment. The times taken to attain a sex ratio of 1 were similar in both groups. The predominance of macrogametocytes seen 'early' post-treatment (on day 3) was later replaced by a predominance of microgametocytes (on days 7 and 14). Analysis of the disposition of gametocytaemia, from the time to attain a sex ratio of 1, showed that the area under the curve of the plot of the level of microgametocytaemia upsilon. time and the mean half-life of the microgametocytaemia were significantly greater and microgametocytaemia clearance was significantly slower than the corresponding values for macrogametocytaemia. Although sex ratios in Plasmodium may naturally become more male-biased as the infection progresses, it is possible that PS treatment may have contributed to the male-biased sex ratios observed post-treatment.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antimalarials,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrimethamine,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfadoxine,
http://linkedlifedata.com/resource/pubmed/chemical/sulfadoxine-pyrimethamine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0003-4983
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
97
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
671-82
|
pubmed:dateRevised |
2009-5-18
|
pubmed:meshHeading |
pubmed-meshheading:14613626-Antimalarials,
pubmed-meshheading:14613626-Area Under Curve,
pubmed-meshheading:14613626-Child,
pubmed-meshheading:14613626-Drug Combinations,
pubmed-meshheading:14613626-Drug Resistance,
pubmed-meshheading:14613626-Female,
pubmed-meshheading:14613626-Germ Cells,
pubmed-meshheading:14613626-Humans,
pubmed-meshheading:14613626-Malaria, Falciparum,
pubmed-meshheading:14613626-Male,
pubmed-meshheading:14613626-Pyrimethamine,
pubmed-meshheading:14613626-Recurrence,
pubmed-meshheading:14613626-Sex Ratio,
pubmed-meshheading:14613626-Sulfadoxine,
pubmed-meshheading:14613626-Time Factors,
pubmed-meshheading:14613626-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
Gametocyte sex ratios in children with asymptomatic, recrudescent, pyrimethamine-sulfadoxine-resistant, Plasmodium falciparum malaria.
|
pubmed:affiliation |
Department of Pharmacology and Therapeutics and Institute for Medical Research and Training, University of Ibadan, Ibadan, Nigeria. malaria.iba@alpha.linkserve.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|